E-LIB Suche - Ergebnisse für: Daizadeh, Nadia S.

1

Safety Observations With 3 Years of Denosumab Exposure: Com..:

Watts, Nelson B ; Brown, Jacques P ; Papapoulos, Socrates...
Journal of Bone and Mineral Research. 32 (2017) 7 - p. 1481-1485 , 2017

Link: https://doi.org/10.1002/..

2

Influence of subject discontinuation on long-term nonverteb..:

Adachi, Jonathan D. ; Bone, Henry G. ; Daizadeh, Nadia S....
BMC Musculoskeletal Disorders. 18 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

3

The Effect of Three or Six Years of Denosumab Exposure in W..:

Bone, Henry G. ; Chapurlat, Roland ; Brandi, Maria-Luisa...
The Journal of Clinical Endocrinology & Metabolism. 98 (2013) 11 - p. 4483-4492 , 2013

Link: https://doi.org/10.1210/..

4

RANKL Inhibition With Denosumab Does Not Influence 3-Year P..:

Samelson, Elizabeth J ; Miller, Paul D ; Christiansen, Claus...
Journal of Bone and Mineral Research. 29 (2013) 2 - p. 450-457 , 2013

Link: https://doi.org/10.1002/..

5

Influence of subject discontinuation on long-term nonverteb..:

Adachi, Jonathan D ; Bone, Henry G ; Daizadeh, Nadia S...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12891-017-1520-6. , 2017

Link: https://archive-ouverte...

6

RANKL Inhibition With Denosumab Does Not Influence 3-year P..:

Samelson, Elizabeth J ; Miller, Paul D ; Christiansen, Claus...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

7

Conjunctivitis in Dupilumab Clinical Trials for Adolescents..:

Bansal, Ashish ; Simpson, Eric L. ; Paller, Amy S....
American Journal of Clinical Dermatology. 22 (2021) 1 - p. 101-115 , 2021

Link: https://doi.org/10.1007/..

8

Efficacy and safety of alemtuzumab over 6 years: final resu..:

Coles, Alasdair J. ; Arnold, Douglas L. ; Bass, Ann D....
Therapeutic Advances in Neurological Disorders. 14 (2021) - p. 175628642098213 , 2021

Link: https://doi.org/10.1177/..

9

Proportion of alemtuzumab-treated patients converting from ..:

Horáková, Dana ; Boster, Aaron ; Bertolotto, Antonio...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 6 (2020) 4 - p. 205521732097213 , 2020

Link: https://doi.org/10.1177/..

10

Postpartum Relapse After First On-Study Pregnancy in RRMS P..:

Celius, Elisabeth G. ; Oh, Jiwon ; Achiron, Anat...
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

11

Long-term efficacy and safety of alemtuzumab in patients wi..:

Steingo, Brian ; Al Malik, Yaser ; Bass, Ann D....
Journal of Neurology. 267 (2020) 11 - p. 3343-3353 , 2020

Link: https://doi.org/10.1007/..

12

Infection risk with alemtuzumab decreases over time: pooled..:

Wray, Sibyl ; Havrdova, Eva ; Snydman, David R...
Multiple Sclerosis Journal. 25 (2018) 12 - p. 1605-1617 , 2018

Link: https://doi.org/10.1177/..

13

Influence of subject discontinuation on long-term nonverteb..:

Jonathan D. Adachi ; Henry G. Bone ; Nadia S. Daizadeh...
http://link.springer.com/article/10.1186/s12891-017-1520-6. , 2017

Link: https://doi.org/10.1186/..

14

Efficacy and Safety of Alemtuzumab Through 9 Years of Follo..:

Ziemssen, Tjalf ; Bass, Ann D ; Berkovich, Regina...
Ziemssen , T , Bass , A D , Berkovich , R , Comi , G , Eichau , S , Hobart , J , Hunter , S F , LaGanke , C , Limmroth , V , Pelletier , D , Pozzilli , C , Schippling , S , Sousa , L , Traboulsee , A , Uitdehaag , B M J , Van Wijmeersch , B , Choudhry , Z , Daizadeh , N , Singer , B A & CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ investigators 2020 , ' Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease : Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study ' , CNS Drugs , vol. 34 , no. 9 , pp. 973-988 . https://doi.org/10.1007/s40263-020-00749-x. , 2020

Link: https://research.vumc.nl..

15

Alemtuzumab outcomes by age:Post hoc analysis from the rand..:

Bass, Ann D ; Arroyo, Rafael ; Boster, Aaron L...
Bass , A D , Arroyo , R , Boster , A L , Boyko , A N , Eichau , S , Ionete , C , Limmroth , V , Navas , C , Pelletier , D , Pozzilli , C , Ravenscroft , J , Sousa , L , Tintoré , M , Uitdehaag , B M J , Baker , D P , Daizadeh , N , Choudhry , Z , Rog , D & CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ investigators 2021 , ' Alemtuzumab outcomes by age : Post hoc analysis from the randomized CARE-MS studies over 8 years ' , Multiple Sclerosis and Related Disorders , vol. 49 , 102717 . https://doi.org/10.1016/j.msard.2020.102717. , 2021

Link: https://research.vumc.nl..